secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001753926-25-001254
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q2 2025 revenue $7.3M, net loss $1.0M; ships 19 SRT systems, FDA volume up 27% sequentially
--------------------------------------------------------------------------------

- Revenue $7.3M vs $9.2M YoY; net loss $1.0M ($0.06/sh) vs net income $1.6M ($0.10/sh) in Q2 2024.
- Shipped 19 SRT systems, including 4 to China; signed 5 new Fair Deal Agreements, 4 live; FDA volume +27% seq.
- Gross margin fell to 39.7% from 58.7% on lower sales and higher service costs; adjusted EBITDA negative $1.8M.
- Ended quarter with $22.2M cash and no debt; engaged Radiology Oncology Systems as distribution partner for hospitals.
- Proposed Physician Fee Schedule expected to align outpatient SRT reimbursement with hospital rates starting Jan 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000175392625001254/0001753926-25-001254-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000175392625001254/g084908_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-001254

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer